Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. cut its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 55.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,056 shares of the company’s stock after selling 10,121 shares during the period. Crossmark Global Holdings Inc.’s holdings in Doximity were worth $351,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the business. Farther Finance Advisors LLC boosted its stake in Doximity by 324.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after purchasing an additional 603 shares during the period. LRI Investments LLC purchased a new position in shares of Doximity during the first quarter valued at $27,000. Blue Trust Inc. raised its position in Doximity by 621.4% during the second quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock valued at $37,000 after buying an additional 1,193 shares during the period. GAMMA Investing LLC lifted its stake in Doximity by 40.1% in the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after acquiring an additional 412 shares in the last quarter. Finally, Quarry LP boosted its position in Doximity by 101.2% during the 2nd quarter. Quarry LP now owns 1,616 shares of the company’s stock worth $45,000 after acquiring an additional 131,253 shares during the period. 87.19% of the stock is currently owned by institutional investors.

Doximity Trading Down 5.1 %

NASDAQ DOCS opened at $49.40 on Monday. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $61.75. The company has a fifty day simple moving average of $43.40 and a 200 day simple moving average of $34.25. The company has a market cap of $9.22 billion, a P/E ratio of 56.78, a P/E/G ratio of 4.09 and a beta of 1.30.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. Robert W. Baird upped their target price on Doximity from $41.00 to $45.00 and gave the company an “outperform” rating in a report on Tuesday, September 17th. KeyCorp upgraded shares of Doximity from a “sector weight” rating to an “overweight” rating and set a $70.00 price objective on the stock in a research note on Friday, November 8th. Baird R W raised shares of Doximity to a “strong-buy” rating in a research note on Tuesday, September 17th. Evercore ISI boosted their price target on shares of Doximity from $34.00 to $45.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Finally, Bank of America increased their price objective on Doximity from $32.00 to $45.00 and gave the stock a “neutral” rating in a report on Monday, October 7th. Eleven investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $51.07.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.